Global Information
회사소개 | 문의

세계의 백금 항암제 시장 : 예측(-2025년)

Global Platinum based Cancer Drug Market Insights, Forecast to 2025

리서치사 QYResearch
발행일 2018년 11월 상품 코드 747131
페이지 정보 영문 171 Pages
가격
US $ 3,900 ₩ 4,443,600 PDF by E-mail (Single User License)
US $ 7,800 ₩ 8,887,300 PDF by E-mail (Enterprise Wide License)


세계의 백금 항암제 시장 : 예측(-2025년) Global Platinum based Cancer Drug Market Insights, Forecast to 2025
발행일 : 2018년 11월 페이지 정보 : 영문 171 Pages

최근 세계 백금 항암제 시장은 평균 성장률이 5.76%, 2017년 세계 백금 항암제 시장 매출은 12억 8,500만 달러에 이르렀습니다.

세계의 백금 항암제(Platinum based Cancer) 시장에 대해 조사 분석했으며, 제조업체별·종류별·용도별·지역별 시장 상황과 예측 등에 대해 정리했습니다.

제1장 조사 개요

  • 백금 항암제 제품
  • 주요 시장 세분화
  • 본 보고서에서 다룬 주요 제조업체
  • 시장 세분화 : 종류별
  • 시장 세분화 : 용도별
  • 조사 목적
  • 조사 대상 기간

제2장 주요 요약

제3장 상세 데이터 : 제조업체별

제4장 상세 데이터 : 종류별

제5장 상세 데이터 : 용도별

제6장 북미

제7장 유럽

제8장 아시아태평양

제9장 중남미

제10장 중동 및 아프리카

제11장 백금 항암제 산업의 주요 제조업체 분석

  • Sanofi
  • Hengrui Medicine
  • ASK Pharma
  • Yi Bai Pharmaceutical
  • Qilu Pharmaceutical
  • Teva
  • Pfizer
  • Dr Reddy's Laboratories
  • Mylan
  • Sun Pharma
  • Novartis
  • Debiopharm
  • Accord Healthcare
  • SK Chemicals

제12장 시장 기회, 과제, 위험, 영향요인 분석

제13장 밸류체인, 판매채널 분석

제14장 주요 조사결과

제15장 부록

LSH 18.11.29

List of Tables and Figures

  • Figure Platinum based Cancer Drug Product Picture
  • Table Platinum based Cancer Drug Key Market Segments
  • Table Key Manufacturers Platinum based Cancer Drug Covered
  • Table Global Platinum based Cancer Drug Market Size Growth Rate by Type (2018-2025) (K Unit) & (M USD)
  • Figure Global Platinum based Cancer Drug Sales Market Share by Type in 2017
  • Figure Cisplatin Product Picture
  • Figure Oxaliplatin Product Picture
  • Figure Carboplatin Product Picture
  • Table Global Platinum based Cancer Drug Market Size Growth Rate by Application (2018-2025) (K Unit)
  • Figure Colorectal Cancer
  • Figure Ovarian Cancer
  • Figure Lung Cancer
  • Figure Platinum based Cancer Drug Report Years Considered
  • Figure Global Platinum based Cancer Drug Market Size 2013-2025 (M USD)
  • Figure Global Platinum based Cancer Drug Sales 2013-2025 (K Unit)
  • Table Global Platinum based Cancer Drug Market Size by Regions 2018-2025 (K Unit) & (M USD)
  • Table Global Platinum based Cancer Drug Sales by Regions 2013-2018 (K Unit)
  • Table Global Platinum based Cancer Drug Sales by Regions 2019-2025 (K Unit)
  • Figure Global Platinum based Cancer Drug Sales Market Share by Regions 2013-2025
  • Figure 2017 Global Platinum based Cancer Drug Sales Market Share by Regions
  • Table Global Platinum based Cancer Drug Revenue by Regions 2013-2018 (M USD)
  • Table Global Platinum based Cancer Drug Revenue by Regions 2019-2025 (M USD)
  • Figure Global Platinum based Cancer Drug Revenue Market Share by Regions 2013-2025
  • Figure Global Platinum based Cancer Drug Revenue Market Share by Regions in 2017
  • Table Global Platinum based Cancer Drug Sales by Manufacturers (2017-2018) (K Unit)
  • Table Global Platinum based Cancer Drug Sales Share by Manufacturers (2017-2018)
  • Figure Global Platinum based Cancer Drug Sales Share by Manufacturers in 2017
  • Table Platinum based Cancer Drug Revenue by Manufacturers (2017-2018) (Million USD)
  • Table Platinum based Cancer Drug Revenue Share by Manufacturers (2017-2018)
  • Figure Platinum based Cancer Drug Value Share by Manufacturers in 2017
  • Figure 2017 Platinum based Cancer Drug Revenue Market Share of Top 5 Manufacturers
  • Table Key Manufacturers Platinum based Cancer Drug Price (2017-2018) (USD/Unit)
  • Table Table Manufacturers Platinum based Cancer Drug Headquarters and Established
  • Table Global Platinum based Cancer Drug Sales by Type (2013-2018) (K Unit)
  • Table Global Platinum based Cancer Drug Sales by Type (2019-2025) (K Unit)
  • Figure Global Platinum based Cancer Drug Sales Market Share by Type (2013-2025)
  • Figure Global Platinum based Cancer Drug Sales Market Share by Type in 2017
  • Table Global Platinum based Cancer Drug Revenue by Type (2013-2018) (M USD)
  • Table Global Platinum based Cancer Drug Revenue by Type (2019-2025) (M USD)
  • Figure Global Platinum based Cancer Drug Revenue Market Share by Type (2013-2025)
  • Figure Global Platinum based Cancer Drug Revenue Market Share by Type in 2017
  • Table Platinum based Cancer Drug Price by Type 2013-2018 (USD/Unit)
  • Table Global Platinum based Cancer Drug Market Size Growth Rate by Application (2018-2025) (K Unit)
  • Table Global Platinum based Cancer Drug Sales by Application (2013-2018) (K Unit)
  • Table Global Platinum based Cancer Drug Sales by Application (2019-2025) (K Unit)
  • Figure Global Platinum based Cancer Drug Sales Share by Application (2013-2025)
  • Figure Global Platinum based Cancer Drug Market Share by Application in 2017
  • Figure North America Platinum based Cancer Drug Sales Growth Rate 2013-2025 (K Unit)
  • Figure North America Platinum based Cancer Drug Revenue Growth Rate 2013-2025 (M USD)
  • Table North America Platinum based Cancer Drug Sales by Countries (2013-2018) (K Unit)
  • Table North America Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
  • Figure North America Platinum based Cancer Drug Sales Market Share by Countries in 2018
  • Table North America Platinum based Cancer Drug Revenue by Countries (2013-2018) (M USD)
  • Table North America Platinum based Cancer Drug Revenue Market Share by Countries (2013-2018)
  • Figure North America Platinum based Cancer Drug Revenue Market Share by Countries in 2018
  • Figure United States Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure United States Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure Canada Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Canada Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure Mexico Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Mexico Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Table North America Platinum based Cancer Drug Sales by Type (2013-2018) (K Unit)
  • Table North America Platinum based Cancer Drug Sales Market Share by Type (2013-2018)
  • Figure 2017 North America Platinum based Cancer Drug Market Share by Type
  • Table North America Platinum based Cancer Drug Sales by Application (2013-2018) (K Unit)
  • Table North America Platinum based Cancer Drug Sales Market Share by Application (2013-2018)
  • Figure 2017 North America Platinum based Cancer Drug Market Share by Application
  • Table North America Platinum based Cancer Drug Sales by Company (2017-2018) (K Unit)
  • Table North America Platinum based Cancer Drug Sales Market Share by Company (2017-2018)
  • Figure North America Platinum based Cancer Drug Sales Market Share by Company in 2017
  • Figure Europe Platinum based Cancer Drug Sales Growth Rate 2013-2025 (K Unit)
  • Figure Europe Platinum based Cancer Drug Revenue Growth Rate 2013-2025 (M USD)
  • Table Europe Platinum based Cancer Drug Sales by Countries (2013-2018) (K Unit)
  • Table Europe Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
  • Figure 2017 Europe Platinum based Cancer Drug Sales Market Share by Countries
  • Table Europe Platinum based Cancer Drug Revenue by Countries (2013-2018) (M USD)
  • Table Europe Platinum based Cancer Drug Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Europe Platinum based Cancer Drug Revenue Market Share by Countries
  • Figure Germany Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Germany Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure France Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure France Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure UK Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure UK Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure Italy Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Italy Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure Russia Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Russia Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Table Europe Platinum based Cancer Drug Sales by Type (2013-2018) (K Unit)
  • Table Europe Platinum based Cancer Drug Sales Market Share by Type (2013-2025)
  • Figure 2017 Europe Platinum based Cancer Drug Market Share by Type
  • Table Europe Platinum based Cancer Drug Sales by Application (2013-2025) (K Unit)
  • Table Europe Platinum based Cancer Drug Sales Market Share by Application (2013-2025)
  • Figure 2017 Europe Platinum based Cancer Drug Market Share by Application
  • Table Europe Platinum based Cancer Drug Sales by Company (2017-2018) (K Unit)
  • Table Europe Platinum based Cancer Drug Sales Market Share by Company (2017-2018)
  • Figure Europe Platinum based Cancer Drug Sales Market Share by Company in 2017
  • Figure Asia Pacific Platinum based Cancer Drug Sales Growth Rate 2013-2025 (K Unit)
  • Figure Asia Pacific Platinum based Cancer Drug Revenue Growth Rate 2013-2025 (M USD)
  • Table Asia Pacific Platinum based Cancer Drug Sales by Countries (2013-2018) (K Unit)
  • Table Asia Pacific Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Platinum based Cancer Drug Sales Market Share by Countries
  • Table Asia Pacific Platinum based Cancer Drug Revenue by Countries (2013-2025) (M USD)
  • Table Asia Pacific Platinum based Cancer Drug Revenue Market Share by Countries (2013-2025)
  • Figure 2017 Asia Pacific Platinum based Cancer Drug Revenue Market Share by Countries
  • Figure China Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure China Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure Japan Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Japan Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure Korea Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Korea Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure India Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure India Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure Southeast Asia Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Southeast Asia Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Table Asia Pacific Platinum based Cancer Drug Sales by Type (2013-2018) (K Unit)
  • Table Asia Pacific Platinum based Cancer Drug Sales Market Share by Type (2013-2018)
  • Figure 2017 Asia Pacific Platinum based Cancer Drug Market Share by Type
  • Table Asia Pacific Platinum based Cancer Drug Sales by Application (2013-2018) (K Unit)
  • Table Asia Pacific Platinum based Cancer Drug Sales Market Share by Application (2013-2018)
  • Figure 2017 Asia Pacific Platinum based Cancer Drug Market Share by Application
  • Table Asia Pacific Platinum based Cancer Drug Sales by Company (2017-2018) (K Unit)
  • Table Asia Pacific Platinum based Cancer Drug Sales Market Share by Company (2017-2018)
  • Figure Asia Pacific Platinum based Cancer Drug Sales Market Share by Company in 2017
  • Figure Central & South America Platinum based Cancer Drug Sales Growth Rate 2013-2025 (K Unit)
  • Figure Central & South America Platinum based Cancer Drug Revenue Growth Rate 2013-2025 (M USD)
  • Table Central & South America Platinum based Cancer Drug Sales by Countries (2013-20218 (K Unit)
  • Table Central & South America Platinum based Cancer Drug Sales Market Share by Countries (2013-2025)
  • Figure 2017 Central & South America Platinum based Cancer Drug Sales Market Share by Countries
  • Table Central & South America Platinum based Cancer Drug Revenue by Countries (2013-2018) (M USD)
  • Table Central & South America Platinum based Cancer Drug Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Central & South America Platinum based Cancer Drug Revenue Market Share by Countries
  • Figure Brazil Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Brazil Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure Argentina Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Argentina Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure Columbia Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Columbia Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Table Central & South America Platinum based Cancer Drug Sales by Type (2013-2018) (K Unit)
  • Table Central & South America Platinum based Cancer Drug Sales Market Share by Type (2013-2018)
  • Figure 2017 Central & South America Platinum based Cancer Drug Market Share by Type
  • Table Central & South America Platinum based Cancer Drug Sales by Application (2013-2018) (K Unit)
  • Table Central & South America Platinum based Cancer Drug Sales Market Share by Application (2013-2018)
  • Figure 2017 Central & South America Platinum based Cancer Drug Market Share by Application
  • Table Central & South America Platinum based Cancer Drug Sales by Company (2017-2018) (K Unit)
  • Table Central & South America Platinum based Cancer Drug Sales Market Share by Company (2017-2018)
  • Figure Central & South America Platinum based Cancer Drug Sales Market Share by Company in 2017
  • Figure Middle East and Africa Platinum based Cancer Drug Sales Growth Rate 2013-2025 (K Unit)
  • Figure Middle East and Africa Platinum based Cancer Drug Revenue Growth Rate 2013-2025 (M USD)
  • Table Middle East and Africa Platinum based Cancer Drug Sales by Countries (2013-2018) (K Unit)
  • Table Middle East and Africa Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Platinum based Cancer Drug Sales Market Share by Countries
  • Table Middle East and Africa Platinum based Cancer Drug Revenue by Countries (2013-2025) (M USD)
  • Table Middle East and Africa Platinum based Cancer Drug Revenue Market Share by Countries (2013-2025)
  • Figure 2017 Middle East and Africa Platinum based Cancer Drug Revenue Market Share by Countries
  • Figure Saudi Arabia Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Saudi Arabia Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure UAE Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure UAE Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure Egypt Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Egypt Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure South Africa Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure South Africa Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Figure Nigeria Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
  • Figure Nigeria Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
  • Table Middle East and Africa Platinum based Cancer Drug Sales by Type (2013-2018) (K Unit)
  • Table Middle East and Africa Platinum based Cancer Drug Sales Market Share by Type (2013-2018)
  • Figure 2017 Middle East and Africa Platinum based Cancer Drug Market Share by Type
  • Table Middle East and Africa Platinum based Cancer Drug Sales by Application (2013-2018) (K Unit)
  • Table Middle East and Africa Platinum based Cancer Drug Sales Market Share by Application (2013-2018)
  • Figure 2017 Middle East and Africa Platinum based Cancer Drug Market Share by Application
  • Table Middle East and Africa Platinum based Cancer Drug Sales by Company (2017-2018) (K Unit)
  • Table Middle East and Africa Platinum based Cancer Drug Sales Market Share by Company (2017-2018)
  • Figure Middle East and Africa Platinum based Cancer Drug Sales Market Share by Company in 2017
  • Table Sanofi Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Sanofi
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Sanofi 2017-2018
  • Table Hengrui Medicine Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Hengrui Medicine
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Hengrui Medicine 2017-2018
  • Table ASK Pharma Company Profile
  • Figure Platinum based Cancer Drug Product Picture of ASK Pharma
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of ASK Pharma 2017-2018
  • Table Yi Bai Pharmaceutical Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Yi Bai Pharmaceutical
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Yi Bai Pharmaceutical 2017-2018
  • Table Qilu Pharmaceutical Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Qilu Pharmaceutical
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Qilu Pharmaceutical 2017-2018
  • Table Teva Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Teva
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Teva 2017-2018
  • Table Pfizer Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Pfizer
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Pfizer 2017-2018
  • Table Dr Reddy's Laboratories Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Dr Reddy's Laboratories
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Dr Reddy's Laboratories 2017-2018
  • Table Mylan Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Mylan
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Mylan 2017-2018
  • Table Sun Pharma Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Sun Pharma
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Sun Pharma 2017-2018
  • Table Novartis Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Novartis
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Novartis 2017-2018
  • Table Debiopharm Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Debiopharm
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Debiopharm 2017-2018
  • Table Accord Healthcare Company Profile
  • Figure Platinum based Cancer Drug Product Picture of Accord Healthcare
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD), Gross Margin and Market Share of Accord Healthcare 2017-2018
  • Table SK Chemicals Company Profile
  • Figure Platinum based Cancer Drug Product Picture of SK Chemicals
  • Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of SK Chemicals 2017-2018
  • Figure New Active Substance Launches 2011-2015 by Indication
  • Figure Immuno-Oncology PD-1 Inhibitor Uptake in the U.S.
  • Figure Growth of the Late Phase Oncology Pipeline, 2005-2015
  • Figure Key In-Market and Investigational Agents for NSCLC
  • Figure Key In-Market and Investigational Agents for Melanoma
  • Figure the Global Late Phase Oncology Pipeline in 2015
  • Figure Companies with Active Late Phase Oncology Pipelines
  • Figure Cancer Incidence by Country in 2014
  • Figure Cancer Mortality by Country in 2014
  • Figure USA numbers of new cancer cases for 2015
  • Figure GDP by Regions / Largest Economies Pie Chart in 2016
  • Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
  • Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
  • Figure Saving Rate Total, % of GDP, 2015
  • Figure Platinum based Cancer Drug Value Chain
  • Figure typical phases from research to the market for a drug candidate
  • Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
  • Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
  • Table Platinum based Cancer Drug Customers List
  • Figure Marketing Channel for Biopharmaceuticals
  • Figure Conceptual Model of the Flow of Products, Services and Funds for Non-specialty Drugs Coveredunder Private Insurance and Purchased in a Retail Setting
  • Figure Marketing Channel for Biopharmaceuticals
  • Table Platinum based Cancer Drug Distributors List
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources

This report studies the Platinum based Cancer Drug market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Platinum based Cancer Drug market by product type and applications/end industries.

In the last several years, global market of platinum based cancer drug developed smoothly, with an average growth rate of 5.76%. In 2017, global revenue of platinum based cancer drug is nearly 1285 M USD; the actual sales are about 25236 K Units

The major players in global Platinum based Cancer Drug market include:

  • Sanofi
  • Hengrui Medicine
  • ASK Pharma
  • Yi Bai Pharmaceutical
  • Qilu Pharmaceutical
  • Teva
  • Pfizer
  • Dr Reddy's Laboratories
  • Mylan
  • Sun Pharma
  • Novartis
  • Debiopharm
  • Accord Healthcare
  • SK Chemicals

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Platinum based Cancer Drug in these regions, from 2013 to 2025 (forecast), covering:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

On the basis of product, the Platinum based Cancer Drug market is primarily split into:

  • Cisplatin
  • Oxaliplatin
  • Carboplatin
  • Other

On the basis on the end users/applications, this report covers:

  • Colorectal Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Other

Table of Contents

1. Study Coverage

  • 1.1. Platinum based Cancer Drug Product
  • 1.2. Key Market Segments
  • 1.3. Key Manufacturers Covered
  • 1.4. Market by Type
    • 1.4.1. Global Platinum based Cancer Drug Market Size Growth Rate by Type
    • 1.4.2. Cisplatin
    • 1.4.3. Oxaliplatin
    • 1.4.4. Carboplatin
  • 1.5. Market by Application
    • 1.5.1. Global Platinum based Cancer Drug Market Size Growth Rate by Application
    • 1.5.2. Colorectal Cancer
    • 1.5.3. Ovarian Cancer
    • 1.5.4. Lung Cancer
  • 1.6. Study Objectives
  • 1.7. Years Considered

2. Executive Summary

  • 2.1. Global Platinum based Cancer Drug Market Size
    • 2.1.1. Global Platinum based Cancer Drug Revenue 2013-2025
    • 2.1.2. Global Platinum based Cancer Drug Sales 2013-2025
  • 2.2. Platinum based Cancer Drug Growth Rate by Regions
    • 2.2.1. Global Platinum based Cancer Drug Sales by Regions
    • 2.2.2. Global Platinum based Cancer Drug Revenue by Regions

3. Breakdown Data by Manufacturers

  • 3.1. Platinum based Cancer Drug Sales by Manufacturers
    • 3.1.1. Platinum based Cancer Drug Sales by Manufacturers
    • 3.1.2. Platinum based Cancer Drug Sales Market Share by Manufacturers
  • 3.2. Platinum based Cancer Drug Revenue by Manufacturers
    • 3.2.1. Platinum based Cancer Drug Revenue by Manufacturers (2017-2018)
    • 3.2.2. Platinum based Cancer Drug Revenue Share by Manufacturers (2017-2018)
    • 3.2.3. Global Platinum based Cancer Drug Market Concentration Ratio
  • 3.3. Platinum based Cancer Drug Price by Manufacturers
  • 3.4. Platinum based Cancer Drug Headquarters and Established
  • 3.5. Manufacturers Mergers & Acquisitions, Expansion Plans

4. Breakdown Data by Type

  • 4.1. Global Platinum based Cancer Drug Sales by Type
  • 4.2. Global Platinum based Cancer Drug Revenue by Type
  • 4.3. Platinum based Cancer Drug Price by Type

5. Breakdown Data by Application

  • 5.1. Overview
  • 5.2. Global Platinum based Cancer Drug Breakdown Data by Application

6. North America

  • 6.1. North America Platinum based Cancer Drug by Countries
    • 6.1.1. North America Platinum based Cancer Drug Sales by Countries
    • 6.1.2. North America Platinum based Cancer Drug Revenue by Countries
    • 6.1.3. United States
    • 6.1.4. Canada
    • 6.1.5. Mexico
  • 6.2. North America Platinum based Cancer Drug by Type
  • 6.3. North America Platinum based Cancer Drug by Application
  • 6.4. North America Platinum based Cancer Drug by Company

7. Europe

  • 7.1. Europe Platinum based Cancer Drug by Countries
    • 7.1.1. Europe Platinum based Cancer Drug Sales by Countries
    • 7.1.2. Europe Platinum based Cancer Drug Revenue by Countries
    • 7.1.3. Germany
    • 7.1.4. France
    • 7.1.5. UK
    • 7.1.6. Italy
    • 7.1.7. Russia
  • 7.2. Europe Platinum based Cancer Drug by Type
  • 7.3. Europe Platinum based Cancer Drug by Application
  • 7.4. Europe Platinum based Cancer Drug by Company

8. Asia Pacific

  • 8.1. Asia Pacific Platinum based Cancer Drug by Countries
    • 8.1.1. Asia Pacific Platinum based Cancer Drug Sales by Countries
    • 8.1.2. Asia Pacific Platinum based Cancer Drug Revenue by Countries
    • 8.1.3. China
    • 8.1.4. Japan
    • 8.1.5. Korea
    • 8.1.6. India
    • 8.1.7. Southeast Asia
  • 8.2. Asia Pacific Platinum based Cancer Drug by Type
  • 8.3. Asia Pacific Platinum based Cancer Drug by Application
  • 8.4. Asia Pacific Platinum based Cancer Drug by Company

9. Central & South America

  • 9.1. Central & South America Platinum based Cancer Drug by Countries
    • 9.1.1. Central & South America Platinum based Cancer Drug Sales by Countries
    • 9.1.2. Central & South America Platinum based Cancer Drug Revenue by Countries
    • 9.1.3. Brazil
    • 9.1.4. Argentina
    • 9.1.5. Columbia
  • 9.2. Central & South America Platinum based Cancer Drug by Type
  • 9.3. Central & South America Platinum based Cancer Drug by Application
  • 9.4. Central & South America Platinum based Cancer Drug by Company

10. Middle East and Africa

  • 10.1. Middle East and Africa Platinum based Cancer Drug by Countries
    • 10.1.1. Middle East and Africa Platinum based Cancer Drug Sales by Countries
    • 10.1.2. Middle East and Africa Platinum based Cancer Drug Revenue by Countries
    • 10.1.3. Saudi Arabia
    • 10.1.4. UAE
    • 10.1.5. Egypt
    • 10.1.6. South Africa
    • 10.1.7. Nigeria
  • 10.2. Middle East and Africa Platinum based Cancer Drug by Type
  • 10.3. Middle East and Africa Platinum based Cancer Drug by Application
  • 10.4. Middle East and Africa Platinum based Cancer Drug by Company

11. Analysis of Platinum based Cancer Drug Industry Key Manufacturers

  • 11.1. Sanofi
    • 11.1.1. Company Profile
    • 11.1.2. Product Information
    • 11.1.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.2. Hengrui Medicine
    • 11.2.1. Company Profile
    • 11.2.2. Product Information
    • 11.2.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.3. ASK Pharma
    • 11.3.1. Company Profile
    • 11.3.2. Product Information
    • 11.3.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.4. Yi Bai Pharmaceutical
    • 11.4.1. Company Profile
    • 11.4.2. Product Information
    • 11.4.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.5. Qilu Pharmaceutical
    • 11.5.1. Company Profile
    • 11.5.2. Product Information
    • 11.5.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.6. Teva
    • 11.6.1. Company Profile
    • 11.6.2. Product Information
    • 11.6.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.7. Pfizer
    • 11.7.1. Company Profile
    • 11.7.2. Product Information
    • 11.7.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.8. Dr Reddy's Laboratories
    • 11.8.1. Company Profile
    • 11.8.2. Product Information
    • 11.8.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.9. Mylan
    • 11.9.1. Company Profile
    • 11.9.2. Product Information
    • 11.9.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.10. Sun Pharma
    • 11.10.1. Company Profile
    • 11.10.2. Product Information
    • 11.10.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.11. Novartis
    • 11.11.1. Company Profile
    • 11.11.2. Product Information
    • 11.11.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.12. Debiopharm
    • 11.12.1. Company Profile
    • 11.12.2. Product Information
    • 11.12.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.13. Accord Healthcare
    • 11.13.1. Company Profile
    • 11.13.2. Product Information
    • 11.13.3. Sales, Price, Revenue, Gross Margin and Market Share
  • 11.14. SK Chemicals
    • 11.14.1. Company Profile
    • 11.14.2. Product Information
    • 11.14.3. Sales, Price, Revenue, Gross Margin and Market Share

12. Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 12.1. Technology Progress/Risk
    • 12.1.1. New Active Substance Launches 2011-2015 by Indication
    • 12.1.2. Rapid Uptake of New Immune-oncology Drugs Reflects Their Remarkable Clinical Profile and Expansion of Indications
    • 12.1.3. Technology Progress in Related Industry
  • 12.2. Cancer Patients Analysis
    • 12.2.1. Key Facts
    • 12.2.2. Cancer Incidence and Mortality Analysis
  • 12.3. Key World Economic Indicators

13. Value Chain and Sales Channels Analysis

  • 13.1. Value Chain Analysis
    • 13.1.1. Platinum based Cancer Drug R&D Cost Analysis
    • 13.1.2. Platinum based Cancer Drug Customers
  • 13.2. Sales Channels Analysis
    • 13.2.2. Distributors

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
    • 15.1.2. Data Source
  • 15.2. Disclaimer
  • 15.3. Author Details
Back to Top
전화 문의
이용안내
 
BCC Research